- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Allianz Biotechnologie
+ Add to WatchlistDJFF:GR
89.0100 EUR 1.7200 1.90%As of 03:52:37 ET on 06/20/2013.
Snapshot for Allianz Biotechnologie (DJFF)
| Open: | 90.4300 | High - Low: | 91.5400 - 88.6960 | Primary Exchange: | Frankfurt |
|---|---|---|---|---|---|
| Volume: | 629 | 52-Week Range: | 69.2000 - 100.1800 | Beta vs NBI: | 0.7388 |
Fund Profile & Information for DJFF
Allianz Biotechnologie is an open-end investment fund incorporated in Germany. The Fund's objective is growth. The Fund invests primarily in stocks, warrants and profit sharing certificates. The Fund may also invest in bonds withwarrants and convertible debentures issued by pharmaceutical and biotechnology corporations worldwide.
| Inception Date: | 1998-01-09 | Telephone: | 49-18-03-30-33-11 |
|---|---|---|---|
| Managers: | PAUL WAGNER | ||
| Web Site: | www.allianzgi.de | ||
Fundamentals for DJFF
| NAV | (on 2013-06-19) 91.3200 |
|---|---|
| Assets (M) | (on 2013-06-19) 273.9352 |
| Shares out (M) | 0.00 |
| Market Cap (M) | 0.00 |
| % Premium | -0.65 |
| Average 52-Week % Premium | -0.0863 |
| Fund Leveraged | N |
Dividends for DJFF
| Dividend Type | Omitted |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | - |
| Dividend Yield (ttm) | -% |
Performance for DJFF
| 1-Month | -5.90% | 1-Year | +29.06% |
|---|---|---|---|
| 3-Month | +7.17% | 3-Year | +21.33% |
| Year To Date | +26.36% | 5-Year | +15.65% |
| Expense Ratio | 2.05 |
Top Fund Holdings for DJFF
Filing Date: 02/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | 609,900 | 21,799,215 | 9.607% |
| Gilead Sciences Inc | 647,700 | 21,139,349 | 9.316% |
| Protalix BioTherapeutics Inc | 4,590,800 | 20,261,801 | 8.929% |
| Biogen Idec Inc | 139,344 | 17,608,201 | 7.760% |
| Alexion Pharmaceuticals Inc | 166,469 | 10,962,559 | 4.831% |
| Seattle Genetics Inc | 506,170 | 10,707,865 | 4.719% |
| Isis Pharmaceuticals Inc | 980,610 | 10,618,493 | 4.680% |
| Regeneron Pharmaceuticals Inc | 51,040 | 6,400,731 | 2.821% |
| Perrigo Co | 67,200 | 5,836,719 | 2.572% |
| BioMarin Pharmaceutical Inc | 128,616 | 5,523,873 | 2.434% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page